Description
Hybrid 2-3 days onsite in Cambridge, MA
Our client seeks a hands‑on program leader to drive cross‑functional execution for the Diranersen program as it advances toward Phase 3 protocol development. The role partners with the PDC Lead to convert asset strategy into an integrated plan, align clinical, regulatory, medical, access, commercial, and CMC/Supply functions, and manage governance, risk, timelines, and budgets. The leader will embed patient‑centric insights, integrate competitive and regulatory landscapes, and operate as a connector across a global matrix to maintain momentum and enable high‑quality delivery.
We can facilitate w2 and corp‑to‑corp consultants. For our w2 consultants, we offer a great benefits package that includes Medical, Dental, and Vision benefits, 401k with company matching, and life insurance.
Rate: $103.85 to $124.62/hr. w2
JN -062026-107508
Responsibilities
Partner with the PDC Lead to translate asset strategy into an actionable, integrated program plan that aligns clinical, regulatory, medical, access, and commercial functions.
Drive scenario planning and trade‑off analyses for key strategic decisions and integrate external landscape insights, including competition, regulatory evolution, and advocacy.
Lead coordination across Clinical Development, Regulatory Affairs, Medical and Patient Engagement, Market Access and Commercial, and CMC/Supply to ensure accountability and milestone delivery.
Prepare the DASP and lead communications planning for external milestones, PR and earnings preparation, and internal communications.
Provide oversight of device integration to ensure alignment with overall asset strategy and execution.
Identify and resolve cross‑functional gaps or misalignments and maintain program momentum.
Own the integrated development and operating plan with timelines, critical path, milestones, deliverables, and resource and budget assumptions.
Track performance, drive on‑time, high‑quality execution, and lead risk identification, mitigation, and escalation.
Lead program governance with the PDC Lead, including preparing PDC and sub‑team forums, structuring decision frameworks, and maintaining decision and action logs.
Operate as a central connector across a global matrix and influence senior stakeholders across R&D and Commercial without direct authority.
Foster a high‑performing, accountable, and collaborative team environment with clear roles, decision rights, and ways of working.
Embed patient‑centric thinking by integrating insights from advocacy groups, key opinion leaders, and clinical experts with focus on Alzheimer’s Disease.
Experience Requirements
5+ years of drug development and commercialization experience with strong business acumen and general management perspective.
Demonstrated analytical and leadership skills with a problem‑solving mindset.
Ability to identify priorities, align strategic and tactical plans, and influence and motivate cross‑functional teams.
Strong relationship building and communication skills with the ability to navigate all organizational levels.
Experience establishing and managing external collaborations, including contractual, financial, and compliance considerations.
Strong project leadership and project management skills.
Preferred experience within Product Development & Commercialization, Global Medicines Development, or cross‑functional R&D/commercial teams; neuroscience and launch preparation experience are a plus.
#J-18808-Ljbffr

Program Leader, Diranersen PDC
Eliassen Group · Cambridge, MA, USA ·
- Pay:
- $103.85-$124.62/hr
- Job type:
- Full Time